UK Medical Cannabis Registry: A Clinical Outcomes Analysis for Epilepsy
Abstract Background: A third of epilepsy patients fail to enter seizure remission despite optimal therapeutic management. Cannabis‐based medicinal products (CBMPs)…
Simon Erridge
UK Medical Cannabis Registry: An Analysis of Outcomes of Medical Cannabis Therapy for Hypermobility‐Associated Chronic Pain
Abstract Objective: The study aims to evaluate the clinical outcomes in patients with hypermobility spectrum disorder (HSD) and hypermobile Ehlers–Danlos…
A Preliminary Investigation into the Use of Cannabis Suppositories and Online Mindful Compassion for Improving Sexual Function Among Women Following Gynaecological Cancer Treatment
Abstract Background and Objectives: The impact of gynaecological cancer and its treatments on sexual intimacy can be profound on female…
UK medical cannabis registry: A clinical outcome analysis of medical cannabis therapy in chronic pain patients with and without co‐morbid sleep impairment
Abstract Introduction: Chronic pain (CP) affects 35.0%–51.3% of the UK population, with 67%–88% reporting sleep disturbances. Cannabis‐based medicinal products (CBMPs)…
Assessment of clinical outcomes in patients with inflammatory arthritis: analysis from the UK Medical Cannabis Registry
Abstract The aim of this study was to assess changes in validated patient-reported outcome measures after initiation of cannabis-based medicinal…
Awareness of medical cannabis regulations among UK police officers – a cross-sectional study
Abstract Cannabis-based products for medicinal use were rescheduled in the UK in November 2018. The primary outcomes of this cross-sectional…
UK Medical Cannabis Registry: Assessment of clinical outcomes in patients with insomnia
Abstract Introduction: The primary aim of this study was to assess changes in sleep‐specific health‐related quality of life (HRQoL) for…
UK Medical Cannabis Registry: a case series analyzing clinical outcomes of medical cannabis therapy for generalized anxiety disorder patients
Abstract This study aims to analyze changes in health-related quality of life (HRQoL) and safety in patients with generalized anxiety…
A cohort study comparing the effects of medical cannabis for anxiety patients with and without comorbid sleep disturbance
Abstract Background: Research on cannabis‐based medicinal products (CBMPs) in anxiety remains inconclusive due to a paucity of high‐quality evidence. Studies…
UK Medical Cannabis Registry: An analysis of clinical outcomes of medicinal cannabis therapy for attention‐deficit/hyperactivity disorder
Abstract Aim: This study aims to analyze the health‐related quality of life (HRQoL) and safety outcomes in attention‐deficit/hyperactivity disorder (ADHD)…